| Chris Francis |
WVE |
Ordinary Shares |
Sale |
-34.9% |
$499,593 |
$15.05 |
-33,194 |
61,867 |
26 Feb 2026 |
Direct |
| Chris Francis |
WVE |
Ordinary Shares |
Options Exercise |
71.3% |
|
|
33,194 |
79,767 |
26 Feb 2026 |
Direct |
| Chris Francis |
WVE |
Share Option (right to buy) |
Options Exercise |
-35.2% |
|
|
-33,194 |
61,175 |
26 Feb 2026 |
Direct |
| Kyle Moran |
WVE |
Ordinary Shares |
Sale |
-2.6% |
$48,259 |
$13.45 |
-3,588 |
134,385 |
09 Feb 2026 |
Direct |
| Paul Bolno |
WVE |
Ordinary Shares |
Sale |
-3.66% |
$140,956 |
$13.45 |
-10,480 |
275,520 |
09 Feb 2026 |
Direct |
| Chris Francis |
WVE |
Ordinary Shares |
Sale |
-2.95% |
$25,326 |
$13.45 |
-1,883 |
61,867 |
09 Feb 2026 |
Direct |
| Chandra Vargeese |
WVE |
Ordinary Shares |
Sale |
-0.78% |
$43,417 |
$13.45 |
-3,228 |
408,246 |
09 Feb 2026 |
Direct |
| Kyle Moran |
WVE |
Ordinary Shares |
Award |
49.4% |
|
|
45,625 |
137,973 |
05 Feb 2026 |
Direct |
| Kyle Moran |
WVE |
Share Option (right to buy) |
Award |
|
|
|
273,750 |
273,750 |
05 Feb 2026 |
Direct |
| Paul Bolno |
WVE |
Ordinary Shares |
Award |
136.4% |
|
|
165,000 |
286,000 |
05 Feb 2026 |
Direct |
| Paul Bolno |
WVE |
Share Option (right to buy) |
Award |
|
|
|
1,000,000 |
1,000,000 |
05 Feb 2026 |
Direct |
| Chris Francis |
WVE |
Ordinary Shares |
Award |
155% |
|
|
38,750 |
63,750 |
05 Feb 2026 |
Direct |
| Chris Francis |
WVE |
Share Option (right to buy) |
Award |
|
|
|
232,500 |
232,500 |
05 Feb 2026 |
Direct |
| Chandra Vargeese |
WVE |
Ordinary Shares |
Award |
12.5% |
|
|
45,625 |
411,474 |
05 Feb 2026 |
Direct |
| Chandra Vargeese |
WVE |
Share Option (right to buy) |
Award |
|
|
|
273,750 |
273,750 |
05 Feb 2026 |
Direct |
| Chris Francis |
WVE |
Ordinary Shares |
Sale |
-27.3% |
$150,260 |
$16.03 |
-9,375 |
25,000 |
02 Jan 2026 |
Direct |
| Chris Francis |
WVE |
Ordinary Shares |
Options Exercise |
37.5% |
|
|
9,375 |
34,375 |
02 Jan 2026 |
Direct |
| Chris Francis |
WVE |
Share Option (right to buy) |
Options Exercise |
-100% |
|
|
-9,375 |
0 |
02 Jan 2026 |
Direct |
| GSK plc |
WVE |
Ordinary Shares |
Purchase |
8.76% |
$27,930,000 |
$19.00 |
1,470,000 |
18,245,691 |
11 Dec 2025 |
By Corporation |
| Kyle Moran |
WVE |
Ordinary Shares |
Sale |
-35.9% |
$1,001,979 |
$20.03 |
-50,036 |
89,218 |
09 Dec 2025 |
Direct |
| Kyle Moran |
WVE |
Ordinary Shares |
Options Exercise |
161.6% |
|
|
86,000 |
139,218 |
09 Dec 2025 |
Direct |
| Kyle Moran |
WVE |
Share Option (right to buy) |
Award |
-100% |
|
|
-86,000 |
0 |
09 Dec 2025 |
Direct |
| Heidi L. Wagner |
WVE |
Ordinary Shares |
Sale |
-23.8% |
$189,000 |
$13.50 |
-14,000 |
44,930 |
08 Dec 2025 |
Direct |
| Heidi L. Wagner |
WVE |
Ordinary Shares |
Options Exercise |
36.9% |
|
|
14,000 |
51,930 |
08 Dec 2025 |
Direct |
| Heidi L. Wagner |
WVE |
Share Option (right to buy) |
Options Exercise |
-66.7% |
|
|
-14,000 |
7,000 |
08 Dec 2025 |
Direct |
| Aik Na Tan |
WVE |
Ordinary Shares |
Options Exercise |
|
|
|
119,230 |
70,400 |
08 Dec 2025 |
Direct |
| Aik Na Tan |
WVE |
Ordinary Shares |
Sale |
-84.1% |
$1,823,158 |
$13.58 |
-134,218 |
25,400 |
08 Dec 2025 |
Direct |
| Aik Na Tan |
WVE |
Share Option (right to buy) |
Options Exercise |
-100% |
|
|
-119,230 |
0 |
08 Dec 2025 |
Direct |
| Chris Francis |
WVE |
Ordinary Shares |
Sale |
-94.6% |
$6,427,085 |
$14.57 |
-441,031 |
25,000 |
08 Dec 2025 |
Direct |
| Chris Francis |
WVE |
Ordinary Shares |
Options Exercise |
|
|
|
441,031 |
147,349 |
08 Dec 2025 |
Direct |
| Chris Francis |
WVE |
Share Option (right to buy) |
Options Exercise |
-100% |
|
|
-441,031 |
0 |
08 Dec 2025 |
Direct |
| Kyle Moran |
WVE |
Ordinary Shares |
Sale |
-70.2% |
$3,102,000 |
$14.77 |
-210,000 |
89,218 |
08 Dec 2025 |
Direct |
| Kyle Moran |
WVE |
Ordinary Shares |
Options Exercise |
|
|
|
210,000 |
189,218 |
08 Dec 2025 |
Direct |
| Kyle Moran |
WVE |
Share Option (right to buy) |
Award |
-100% |
|
|
-210,000 |
0 |
08 Dec 2025 |
Direct |
| Gregory L. Verdine |
WVE |
Ordinary Shares |
Sale |
-6.77% |
$269,461 |
$13.47 |
-20,000 |
275,217 |
08 Dec 2025 |
Direct |
| Adrian Rawcliffe |
WVE |
Ordinary Shares |
Sale |
-76.8% |
$630,000 |
$15.00 |
-42,000 |
12,700 |
08 Dec 2025 |
Direct |
| Adrian Rawcliffe |
WVE |
Ordinary Shares |
Options Exercise |
330.7% |
|
|
42,000 |
54,700 |
08 Dec 2025 |
Direct |
| Adrian Rawcliffe |
WVE |
Share Option (right to buy) |
Options Exercise |
-100% |
|
|
-42,000 |
0 |
08 Dec 2025 |
Direct |
| Henry Christian O |
WVE |
Ordinary Shares |
Options Exercise |
|
|
|
87,000 |
54,700 |
08 Dec 2025 |
Direct |
| Henry Christian O |
WVE |
Ordinary Shares |
Sale |
-88% |
$1,369,324 |
$14.65 |
-93,445 |
12,700 |
08 Dec 2025 |
Direct |
| Henry Christian O |
WVE |
Share Option (right to buy) |
Options Exercise |
-100% |
|
|
-87,000 |
0 |
08 Dec 2025 |
Direct |
| Mark Corrigan |
WVE |
Ordinary Shares |
Sale |
-35.9% |
$217,297 |
$13.48 |
-16,115 |
28,815 |
08 Dec 2025 |
Direct |
| Adrian Rawcliffe |
WVE |
Ordinary Shares |
Sale |
-55.9% |
$109,421 |
$6.79 |
-16,115 |
12,700 |
13 Nov 2025 |
Direct |
| Ra Capital Management, L.P. |
WVE |
Ordinary Shares |
Purchase |
0.01% |
$6,688 |
$6.69 |
1,000 |
18,203,009 |
13 Nov 2025 |
See footnotes |
| Gregory L. Verdine |
WVE |
Ordinary Shares |
Sale |
-3.39% |
$100,000 |
$10.00 |
-10,000 |
285,217 |
22 Aug 2025 |
Direct |
| Paul Bolno |
WVE |
Ordinary Shares |
Sale |
-64.2% |
$2,194,810 |
$10.10 |
-217,351 |
121,000 |
22 Aug 2025 |
Direct |
| Aik Na Tan |
WVE |
Ordinary Shares |
Sale |
-34.2% |
$194,250 |
$9.25 |
-21,000 |
40,388 |
15 Aug 2025 |
Direct |
| Aik Na Tan |
WVE |
Ordinary Shares |
Options Exercise |
52% |
|
|
21,000 |
61,388 |
15 Aug 2025 |
Direct |
| Aik Na Tan |
WVE |
Share Option (right to buy) |
Options Exercise |
-100% |
|
|
-21,000 |
0 |
15 Aug 2025 |
Direct |
| Henry Christian O |
WVE |
Ordinary Shares |
Sale |
-24.6% |
$85,193 |
$8.81 |
-9,670 |
29,645 |
13 Aug 2025 |
Direct |